ELIZABETH COYLE to Microbial Sensitivity Tests
This is a "connection" page, showing publications ELIZABETH COYLE has written about Microbial Sensitivity Tests.
Connection Strength
0.507
-
Antifungal susceptibility testing: a primer for clinicians. Pharmacotherapy. 2012 Dec; 32(12):1112-22.
Score: 0.079
-
Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU. J Pharm Pract. 2010 Feb; 23(1):33-7.
Score: 0.065
-
Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006 Aug; 50(8):2626-31.
Score: 0.051
-
Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005 Dec; 49(12):4920-7.
Score: 0.049
-
Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2005 Jun; 52(2):145-51.
Score: 0.047
-
Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis. 2003 Dec 15; 37(12):1643-8.
Score: 0.042
-
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 2001 Jun; 45(6):1654-9.
Score: 0.036
-
Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2001 Mar; 45(3):706-9.
Score: 0.035
-
Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations. Antimicrob Agents Chemother. 2000 Jul; 44(7):1921-4.
Score: 0.033
-
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients. J Antibiot (Tokyo). 2014 Jul; 67(7):505-9.
Score: 0.022
-
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. Int J Antimicrob Agents. 2013 Jun; 41(6):516-20.
Score: 0.020
-
Escherichia coli resistance to quinolones at a comprehensive cancer center. Diagn Microbiol Infect Dis. 2010 Jul; 67(3):266-9.
Score: 0.017
-
Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother. 2005 May; 55(5):792-5.
Score: 0.012